Evidence map›Paper›PMID 35017498›Full record

ArticleNature communications2022

Design principles for site-selective hydroxylation by a Rieske oxygenase.

Jianxin Liu, Jiayi Tian, Christopher Perry, April L Lukowski, Tzanko I Doukov, Alison R H Narayan, Jennifer Bridwell-Rabb

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Emerging classes of copper enzymes.Current opinion in chemical biology · 2026
    Review
  2. Robots and Minimal, Physics-Informed Features: A Hybrid Framework for Enzyme Catalysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Utility-Scale Quantum Computational Chemistry.The journal of physical chemistry letters · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Biosynthesis of guanidine-containing natural products in cyanobacteria.Journal of industrial microbiology & biotechnology · 2024
    Review
  11. Review
  12. Elucidating the Role of OACS environmental Au · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Biocatalytic control of site-selectivity and chain length-selectivity in radical amino acid halogenases.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jianxin LiuDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0000-0001-5713-434X
Jiayi TianDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.
Christopher PerryDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.
April L LukowskiProgram in Chemical Biology, University of Michigan, Ann Arbor, MI, 48109, USA.
Tzanko I DoukovMacromolecular Crystallography Group, Stanford Synchrotron Radiation Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA, 94025, USA.ORCID http://orcid.org/0000-0001-8625-2572
Alison R H NarayanDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA. arhardin@umich.edu.ORCID http://orcid.org/0000-0001-8290-0077
Jennifer Bridwell-RabbDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA. jebridwe@umich.edu.ORCID http://orcid.org/0000-0002-7437-6217

Funding

A Synchrotron Radiation Structural Biology ResourcesP30GM133894 · NIGMS · STANFORD UNIVERSITY · PI Thomas Michael Weiss · 2020 to 2026
$43.3M
Undergrad Supplement: Expanding the synthetic utility of natural product biosynthetic enzymesR35GM124880 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alison Narayan · 2017 to 2026
$4.5M
One, Two, and Three Rieske Routes for Catalyzing Site-Specific Oxygenations: Equipment SupplementR35GM138271 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jennifer D Bridwell-Rabb · 2020 to 2026
$2.4M
Biocatalytic approaches to antiepileptic drug targetsF31NS111906 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKOWSKI, APRIL · 2019 to 2020
$49k
NIGMS NIH HHS P30 GM133894NIGMS NIH HHS R35 GM124880NIGMS NIH HHS R35 GM138271NINDS NIH HHS F31 NS111906
6 · The paper itself

Abstract

Rieske oxygenases exploit the reactivity of iron to perform chemically challenging C-H bond functionalization reactions. Thus far, only a handful of Rieske oxygenases have been structurally characterized and remarkably little information exists regarding how these enzymes use a common architecture and set of metallocenters to facilitate a diverse range of reactions. Herein, we detail how two Rieske oxygenases SxtT and GxtA use different protein regions to influence the site-selectivity of their catalyzed monohydroxylation reactions. We present high resolution crystal structures of SxtT and GxtA with the native β-saxitoxinol and saxitoxin substrates bound in addition to a Xenon-pressurized structure of GxtA that reveals the location of a substrate access tunnel to the active site. Ultimately, this structural information allowed for the identification of six residues distributed between three regions of SxtT that together control the selectivity of the C-H hydroxylation event. Substitution of these residues produces a SxtT variant that is fully adapted to exhibit the non-native site-selectivity and substrate scope of GxtA. Importantly, we also found that these selectivity regions are conserved in other structurally characterized Rieske oxygenases, providing a framework for predictively repurposing and manipulating Rieske oxygenases as biocatalysts.

Indexed as

Catalytic DomainCrystallography, X-RayEscherichia coliEscherichia coli ProteinsHydroxylationIronModels, MolecularOxygenasesSubstrate SpecificityTrans-ActivatorsEscherichia coli ProteinsIronOxygenasesSxy protein, E coliTrans-Activators

Identifiers

PMID35017498
PMCPMC8752792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.